Clinical Efficacy With Ponatinib in the PHALLCON Trial for Ph+ ALL

,

In Partnership With:

OncLive News Network® | <b>Treatment Updates in Ph+ Acute Lymphoblastic Leukemia</b>

Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss the efficacy with ponatinib observed in the PHALLCON trial of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia.